These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 1646086

  • 1. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes.
    Bourgault I, Gomez A, Gomard E, Levy JP.
    Clin Exp Immunol; 1991 Jun; 84(3):501-7. PubMed ID: 1646086
    [Abstract] [Full Text] [Related]

  • 2. Human cytotoxic T lymphocytes. III. Large numbers of peripheral blood T cells clonally develop into allorestricted anti-viral cytotoxic T cell populations in vitro.
    Kabelitz D, Herzog WR, Heeg K, Wagner H, Reimann J.
    J Mol Cell Immunol; 1987 Jun; 3(1):49-60. PubMed ID: 2855406
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CD8high (CD57+) T cells in normal, healthy individuals specifically suppress the generation of cytotoxic T lymphocytes to Epstein-Barr virus-transformed B cell lines.
    Wang EC, Lehner PJ, Graham S, Borysiewicz LK.
    Eur J Immunol; 1994 Nov; 24(11):2903-9. PubMed ID: 7525311
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
    van Binnendijk RS, Poelen MC, de Vries P, Voorma HO, Osterhaus AD, Uytdehaag FG.
    J Immunol; 1989 Apr 15; 142(8):2847-54. PubMed ID: 2467943
    [Abstract] [Full Text] [Related]

  • 8. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
    Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W.
    Virology; 1999 Nov 25; 264(2):289-97. PubMed ID: 10562493
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD4(+) Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood.
    Sun Q, Burton RL, Pollok KE, Emanuel DJ, Lucas KG.
    Cell Immunol; 1999 Aug 01; 195(2):81-8. PubMed ID: 10448007
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of human EBV- and CMV-specific cytolytic effector function using allogeneic HLA molecules.
    D'Orsogna LJ, van den Heuvel H, van der Meer-Prins EM, Roelen DL, Doxiadis II, Claas FH.
    J Immunol; 2012 Nov 15; 189(10):4825-31. PubMed ID: 23077240
    [Abstract] [Full Text] [Related]

  • 12. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.
    Oncol Rep; 2004 Oct 15; 12(4):725-31. PubMed ID: 15375491
    [Abstract] [Full Text] [Related]

  • 13. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA, Kernan NA, Diaz-Barrientos T, Veenhof WF, O'Reilly RJ, Willemze R, Falkenburg JH.
    Bone Marrow Transplant; 1995 Jul 15; 16(1):125-32. PubMed ID: 7581111
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants.
    Moss DJ, Misko IS, Burrows SR, Burman K, McCarthy R, Sculley TB.
    Nature; 1988 Feb 25; 331(6158):719-21. PubMed ID: 2830541
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
    Vandekerckhove BA, Datema G, Koning F, Goulmy E, Persijn GG, Van Rood JJ, Claas FH, De Vries JE.
    J Immunol; 1990 Feb 15; 144(4):1288-94. PubMed ID: 2137487
    [Abstract] [Full Text] [Related]

  • 16. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M.
    Cancer Res; 1995 Aug 15; 55(16):3675-81. PubMed ID: 7627978
    [Abstract] [Full Text] [Related]

  • 17. A virus-specific CD4+ cell-mediated cytolytic activity revealed by CD8+ cell elimination regularly develops in uncloned human antiviral cell lines.
    Bourgault I, Gomez A, Gomard E, Picard F, Levy JP.
    J Immunol; 1989 Jan 01; 142(1):252-6. PubMed ID: 2535856
    [Abstract] [Full Text] [Related]

  • 18. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF, Ladanyi M, Louie DC, Fernandez JM, Papadopoulos EB, O'Reilly RJ.
    J Exp Med; 1996 Mar 01; 183(3):1215-28. PubMed ID: 8642263
    [Abstract] [Full Text] [Related]

  • 19. Restriction of Epstein-Barr virus-specific cytotoxic T cells by HLA-A, -B, and -C molecules.
    Chen BP, Lam V, Kraus EE, DeMars R, Sondel PM.
    Hum Immunol; 1989 Oct 01; 26(2):137-47. PubMed ID: 2479624
    [Abstract] [Full Text] [Related]

  • 20. Individual variation in the frequency of HLA class II-specific cytotoxic T lymphocyte precursors.
    Man S, Lechler RI, Batchelor JR, Sharrock CE.
    Eur J Immunol; 1990 Apr 01; 20(4):847-54. PubMed ID: 2112094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.